Significant agreements - Cancer Research UK (Details) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 04, 2024
GBP (£)
|
Dec. 13, 2016
USD ($)
|
Dec. 31, 2024
USD ($)
|
Dec. 31, 2023
USD ($)
|
|
| Research and development arrangement obligation to repay other parties | ||||
| Contingent future milestones payments under research and development arrangement | $ 50,900 | |||
| Gain on extinguishment of research and development funding liability | $ 4,476 | |||
| BT1718 | ||||
| Research and development arrangement obligation to repay other parties | ||||
| Liability from research and development | $ 4,300 | |||
| Research and Development Arrangement, Upfront Cash Payment | £ | £ 50,000 | |||
| Gain on extinguishment of research and development funding liability | $ 4,500 | |||
| BT1718 | Minimum | ||||
| Research and development arrangement obligation to repay other parties | ||||
| Tiered royalties (percentage) | 70.00% | |||
| BT1718 | Maximum | ||||
| Research and development arrangement obligation to repay other parties | ||||
| Tiered royalties (percentage) | 90.00% |